Glioma Biology and Molecular Markers
Speaker: Dr. Carolyn Marks, R&D Research Scientist, Atlas Antibodies, Sweden
Gliomas are heterogeneous tumors derived from glial cells and remain the deadliest form of brain cancer. This webinar walks through the history of glioma classification, the evolution of the molecular-based classification, and the emergence of an integrated diagnosis.
Learning points:
- Specific molecular markers that revolutionized glioma biology and the clinical ramifications of glioma misclassification.
- A summary of the current genetic, proteomic, and cellular biomarkers of glioma and the current approaches/challenges in glioma diagnosis, therapy, and prognosis.
- Existing and upcoming proteomic resources to aid in overcoming the major hurdles in glioma diagnostics and treatment today.
Webinar hosted by the American Association for Cancer Research (AACR) and sponsored by Atlas Antibodies. This recording is a property of Atlas Antibodies.